Literature DB >> 21986191

Induction of thymic stromal lymphopoietin production by xylene and exacerbation of picryl chloride-induced allergic inflammation in mice.

Nozomi Satou1, Kenji Ishihara, Masahiro Hiratsuka, Hiroyuki Tanaka, Yasuo Endo, Saburo Saito, Yoichiro Iwakura, Warren J Leonard, Noriyasu Hirasawa.   

Abstract

BACKGROUND: Some chemical compounds in the environment worsen allergic inflammation. In this study, we examined whether organic solvents induce the production of thymic stromal lymphopoietin (TSLP) which elicits Th2-type immune responses.
METHODS: Organic solvents were painted on the earlobes of BALB/c mice. The expression of TSLP in the ear was determined by ELISA.
RESULTS: Xylene and toluene, but not chloroform or ethyl acetate, induced the expression of mRNA for TSLP in the earlobe tissue. Among the aromatic compounds, xylene, especially m-xylene, and trimethylbenzene caused apparent TSLP production. The level of TSLP in the xylene-treated earlobes reached a maximum at 24 h, and TSLP was expressed in epithelial tissues. Production of TSLP was unaffected in mast cell-deficient W/W(v) mice but apparently diminished in TNF-α knockout mice and IL-4 receptor knockout mice. Repeated painting of xylene for 7 days induced an increase in the weight of cervical lymph nodes and expression of OX40 ligand, both of which were inhibited in TSLP receptor knockout mice. Xylene promoted the picryl chloride-induced thickening of the ear and IL-4 production, which were reversed in TSLP receptor knockout mice.
CONCLUSION: Xylene induced TSLP production, resulting in an exacerbation of allergic inflammation. Thus, xylene might be a good tool for examining the roles of TSLP in eliciting allergy in experimental animals.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21986191      PMCID: PMC3221269          DOI: 10.1159/000327545

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  25 in total

1.  IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains.

Authors:  N Noben-Trauth; W E Paul; D L Sacks
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

2.  Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes.

Authors:  Y Tagawa; K Sekikawa; Y Iwakura
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

3.  An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice.

Authors:  N Noben-Trauth; L D Shultz; F Brombacher; J F Urban; H Gu; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Cyclophosphamide-induced blood and tissue eosinophilia in contact sensitivity: mechanism of hapten-induced eosinophil recruitment into the skin.

Authors:  T Satoh; Q J Chen; G Sasaki; H Yokozeki; I Katayama; K Nishioka
Journal:  Eur J Immunol       Date:  1997-01       Impact factor: 5.532

5.  Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity.

Authors:  Sun Ying; Brian O'Connor; Jonathan Ratoff; Qiu Meng; Kirsty Mallett; David Cousins; Douglas Robinson; Guizhen Zhang; Jisheng Zhao; Tak H Lee; Chris Corrigan
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

6.  Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity.

Authors:  Yuko Ikezawa; Masatoshi Nakazawa; Chizuru Tamura; Kazuo Takahashi; Mutsuhiko Minami; Zenro Ikezawa
Journal:  J Dermatol Sci       Date:  2005-08       Impact factor: 4.563

7.  FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells.

Authors:  Y Okayama; S Okumura; H Sagara; K Yuki; T Sasaki; N Watanabe; M Fueki; K Sugiyama; K Takeda; T Fukuda; H Saito; C Ra
Journal:  Eur Respir J       Date:  2009-01-22       Impact factor: 16.671

8.  Molecular cloning and biological characterization of a novel murine lymphoid growth factor.

Authors:  J E Sims; D E Williams; P J Morrissey; K Garka; D Foxworthe; V Price; S L Friend; A Farr; M A Bedell; N A Jenkins; N G Copeland; K Grabstein; R J Paxton
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

9.  Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin.

Authors:  Jane Yoo; Miyuki Omori; Dora Gyarmati; Baohua Zhou; Theingi Aye; Avery Brewer; Michael R Comeau; Daniel J Campbell; Steven F Ziegler
Journal:  J Exp Med       Date:  2005-08-15       Impact factor: 14.307

10.  A role for thymic stromal lymphopoietin in CD4(+) T cell development.

Authors:  Amin Al-Shami; Rosanne Spolski; John Kelly; Terry Fry; Pamela L Schwartzberg; Akhilesh Pandey; Crystal L Mackall; Warren J Leonard
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307

View more
  3 in total

1.  Induction of thymic stromal lymphopoietin production by nonanoic acid and exacerbation of allergic inflammation in mice.

Authors:  Saori Yamashita; Ryosuke Segawa; Nozomi Satou; Masahiro Hiratsuka; Warren J Leonard; Noriyasu Hirasawa
Journal:  Allergol Int       Date:  2013-09-25       Impact factor: 5.836

2.  Exopolysaccharide Produced by Lactobacillus paracasei IJH-SONE68 Prevents and Improves the Picryl Chloride-Induced Contact Dermatitis.

Authors:  Masafumi Noda; Nasrin Sultana; Ikue Hayashi; Mitsuhiro Fukamachi; Masanori Sugiyama
Journal:  Molecules       Date:  2019-08-16       Impact factor: 4.411

3.  Fine Particulate Matter (PM2.5) is a Risk Factor for Dermatitis by Promoting the Expression of Thymic Stromal Lymphopoietin (TSLP) in Keratinocytes.

Authors:  Fei Li; Yongpin Dong; Chunya Ni; Haidong Kan; Shuxian Yan
Journal:  Indian J Dermatol       Date:  2020 Mar-Apr       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.